Torii Pharmaceutical Co (TSE:4551) Other Operating Expense : 円12,834 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co Other Operating Expense?

Torii Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was 円3,713 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円12,834 Mil.

Torii Pharmaceutical Co's quarterly Other Operating Expense declined from Sep. 2023 (円3,619 Mil) to Dec. 2023 (円1,796 Mil) but then increased from Dec. 2023 (円1,796 Mil) to Mar. 2024 (円3,713 Mil).

Torii Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2021 (円14,660 Mil) to Dec. 2022 (円12,885 Mil) and declined from Dec. 2022 (円12,885 Mil) to Dec. 2023 (円12,645 Mil).

Torii Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Torii Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torii Pharmaceutical Co Other Operating Expense Chart

Torii Pharmaceutical Co Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

15,071.00

13,083.00

14,660.00

12,885.00

12,645.00

Torii Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															3,524.00	3,706.00	3,619.00	1,796.00	3,713.00

Torii Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円12,834 Mil.

Torii Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Torii Pharmaceutical Co (TSE:4551) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439

Website

http://www.torii.co.jp

Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines